A Picture of Positivity: Sitting Down With Georgios Theodoridis
Tireless advocate for the field, Georgios Theodoridis, discusses his vision for the future of clinical metabolomics
Clinical Scorecard: A Picture of Positivity: Sitting Down With Georgios Theodoridis
At a Glance
Category Detail
Condition Analytical Science Key Mechanisms High-performance liquid chromatography (HPLC) and mass spectrometry (MS) techniques Target Population Students and practitioners in analytical chemistry and related fields Care Setting Academic and clinical laboratories
Key Highlights
HPLC remains a valid and widely used technique in clinical labs. Fundamental knowledge in physical chemistry is crucial for avoiding common mistakes in chromatography. Metabolomics is expected to become a significant part of standard clinical practice. Current focus on type 2 diabetes highlights the complexity of the disease and the role of metabolomics. ThetaBiomarkers aims to develop biomarker panels for clinical decision-making. Guideline-Based Recommendations
Diagnosis
Utilize metabolomics to reveal complexities in diseases like type 2 diabetes. Management
Develop technology-ready methods for clinical applications. Monitoring & Follow-up
Analyze thousands of samples to validate methods for clinical use. Risks
Lack of fundamental knowledge can lead to errors in analytical results. Patient & Prescribing Data
Individuals with type 2 diabetes and metabolic syndrome.
Metabolomics can accurately monitor disease and therapeutic interventions.
Clinical Best Practices
Ensure practitioners have a strong understanding of chromatography principles. Encourage collaboration between analytical scientists and clinicians. Related Resources & Content
